ecopipam (PSYRX 101) / Paragon Biosci 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ecopipam (PSYRX 101) / Paragon Biosci
EBS-101-TD-391, NCT06021522: A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Recruiting
3
150
Europe, Canada, US
Ecopipam, Ecopipam Hydrochloride
Emalex Biosciences Inc.
Tourette Syndrome
11/24
03/27
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Recruiting
3
196
Europe, Canada, US, RoW
Ecopipam Hydrochloride
Emalex Biosciences Inc.
Tourette Disorder
12/24
12/24
2019-000281-37: Study to evaluate efficacy and safety of Ecopipam tablets in children and adolescent patients with Tourette's syndrome.

Not yet recruiting
2
150
Europe
Ecopipam HCl, EBS-101, BS-101, Tablet
Emalex Biosciences, Inc., Emalex Biosciences, Inc.
Children and Adolescent Subjects with Tourette’s Syndrome grater than or equal to 6 and less than 18 years of age., Tourette’s Syndrome is a neurological disorder characterized by motor or vocal tics that begin in childhood and persists over time ., Diseases [C] - Nervous System Diseases [C10]
 
 
EBS-101-HV-105, NCT05841160: Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

Completed
1
29
US
Ecopipam Hydrochloride, Moxifloxacin, Placebo
Emalex Biosciences Inc., PPD, Clario
QT/QTc
05/23
05/23
EBS-101-HV-106, NCT06194864: Drug Interaction Study

Recruiting
1
40
Canada
Itraconazole, rifampicin, Ecopipam
Emalex Biosciences Inc., Syneos Health, Cambridge Cognition Ltd
Drug Interaction
05/24
05/24

Download Options